Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$3,457,281
+$473,971 QoQ
Shares Held
13,739
+0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#1,550
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pinnacle Wealth Planning Services, Inc. holds $20,087,289 across 16 Drug Manufacturers - General names. ABBV ranks #2 (17.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,225 | $5,067,592 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
13,739 | $3,457,281 | |
| 3 | JNJ |
Johnson & Johnson
|
12,008 | $3,049,671 | |
| 4 | AZN |
Astrazeneca PLC
|
10,147 | $1,924,074 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,662 | $1,627,067 | |
| 6 | NVS |
Novartis AG
|
6,438 | $1,008,963 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,465 | $943,128 | |
| 8 | NVO |
Novo Nordisk A S
|
18,951 | $908,510 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,457,281 | 13,739 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,983,310 | 13,717 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,048,970 | 13,344 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,154,037 | 13,622 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,309,112 | 12,440 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $2,563,686 | 12,236 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,148,037 | 12,088 | Shares | Sole | 2025-02-27 | |
| 2024-09-30 | $2,976,616 | 15,073 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,563,709 | 14,947 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,712,561 | 14,896 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,299,289 | 14,837 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,478,718 | 16,629 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,199,331 | 16,324 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $2,715,664 | 17,040 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $2,703,411 | 16,728 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,960,136 | 14,605 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,433,252 | 15,887 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $2,543,992 | 15,693 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $1,976,162 | 14,595 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $1,463,472 | 13,567 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $1,525,032 | 13,539 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,460,212 | 13,493 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $1,366,698 | 12,755 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,103,108 | 12,594 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $1,232,060 | 12,549 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $955,879 | 12,546 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||